Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Perez

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Seminars in Oncology|April 6, 1999
Paclitaxel plus nonanthracycline combinations in metastatic breast cancerE A Perez
Seminars in Oncology|September 7, 2001
Metastatic bone disease in breast cancer: the patient's perspectiveE A Perez
Current Oncology Reports|December 21, 2000
Update on metastatic breast cancerE A Perez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesisE A Perez
Clinical Breast Cancer|April 24, 2002
Rationale and design of a phase III trial of adjuvant sequential epirubicin/ cyclophosphamide and taxane versus concurrent epirubicin/taxane in operable node-positive breast cancerE A Perez
Seminars in Oncology|September 11, 1999
Current management of metastatic breast cancerE A Perez
Breast Cancer Research and Treatment|December 22, 1999
5-HT3 antiemetic therapy for patients with breast cancerE A Perez
Cancer Investigation|April 12, 2001
Doxorubicin and paclitaxel in the treatment of advanced breast cancer: efficacy and cardiac considerationsE A Perez
Oncology (Williston Park, N.Y.)|January 1, 1996
Use of dexamethasone with 5-HT3-receptor antagonistsE A Perez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Schedule-dependent edatrexate toxicityE A Perez
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Seminars in Oncology|April 6, 1999
Paclitaxel plus nonanthracycline combinations in metastatic breast cancerE A Perez
Seminars in Oncology|September 7, 2001
Metastatic bone disease in breast cancer: the patient's perspectiveE A Perez
Current Oncology Reports|December 21, 2000
Update on metastatic breast cancerE A Perez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesisE A Perez
Clinical Breast Cancer|April 24, 2002
Rationale and design of a phase III trial of adjuvant sequential epirubicin/ cyclophosphamide and taxane versus concurrent epirubicin/taxane in operable node-positive breast cancerE A Perez
Seminars in Oncology|September 11, 1999
Current management of metastatic breast cancerE A Perez
Breast Cancer Research and Treatment|December 22, 1999
5-HT3 antiemetic therapy for patients with breast cancerE A Perez
Cancer Investigation|April 12, 2001
Doxorubicin and paclitaxel in the treatment of advanced breast cancer: efficacy and cardiac considerationsE A Perez
Oncology (Williston Park, N.Y.)|January 1, 1996
Use of dexamethasone with 5-HT3-receptor antagonistsE A Perez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Schedule-dependent edatrexate toxicityE A Perez
Pageof 13